Responses to second-line tyrosine kinase inhibitors are durable: an intention-to-treat analysis in chronic myeloid leukemia patients
Authors:
O. Hrodek
Published in:
Transfuze Hematol. dnes,18, 2012, No. 2, p. 86.
Category:
Selection of press reports and books
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2012 Issue 2
Most read in this issue
- Current possibilities of laboratory diagnosis heparin-induced trombocytopenia
- n 18-year old Female with a History of Collapse – Case Report
- Significance of hepcidin level assessment in the diagnosis of selected types of anaemia in childhood
- Identification of Important Pathogenetic Mutations in Chronic Lymphocytic Leukemia Using „Next Generation Sequencing“